Sign in
4

Changes in Ownership

GT Biopharma, Inc. Filed Acc 0001493152-22-019876

Exec. Chair. and Interim CEO acquired 278,058 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Breen Michael Martin · Exec. Chair. and Interim CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-15 Grant or award : show line 1 in the form +278,058 606,218 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-15 Grant or award : show line 2 in the form Option to purchase Common Stock +50,000 50,000 D
Loading xslF345X03/ownership.xml…